I99- diseases of the circulatory system
A study to assess remaining blood-thinner effect after stopping antiplatelet medicines before major cancer surgery using the TEG 6s Test
Who can joinAsk the trial team
AgeAsk the trial team
Kind of studyObservational: no new treatment
What it testsWatches and records only
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)Navi Mumbai, MaharashtraDirections ↗
Registry summary (technical)
Role of TEG 6s for Assessing Residual Antiplatelet action in patient Undergoing Major Oncologic Surgery After Dual antiplatelet drugs Withdrawal. - TEG-ONCO DAPT STUDY
Sponsor: ACTREC, TMC
CTRI/2026/06/112636 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 3 Aug 2026 · read by us 5 Nov 2026